Physician profile
Scott M Everett
NPI 1750636346
$955.25
in general payments reported to CMS, 2019-2025
15 companies · $50.82 in 2025
The $50.82 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2021: $92.86 · 2022: $108 · 2023: $72.47 · 2024: $229 · 2025: $50.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $197 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.04 |
| Education | $155.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $145.44 | 2019-2022 | |
| Medical Device Business Services, INC. | $137.01 | 2024 | Stratafix |
| Csl Behring | $101.12 | 2019 | |
| Edwards Lifesciences Corporation | $100.53 | 2019 | |
| Comsort, INC | $100.00 | 2019 | |
| Masimo Corporation | $94.02 | 2022-2023 | Set and Rainbow Set |
| Merck Sharp & Dohme LLC | $68.54 | 2019-2024 | Bridion |
| Abiomed | $44.44 | 2024 | Impella |
| Eagle Pharmaceuticals, INC. | $38.21 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $34.13 | 2021-2025 | Exparel |
| Becton, Dickinson and Company | $31.51 | 2025 | |
| Heron Therapeutics, INC. | $18.35 | 2023 | Zynrelef |
| Innocoll Pharmaceuticals Limited | $16.40 | 2021 | |
| Ge Healthcare | $13.11 | 2024 | |
| Acacia Pharma INC | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Everett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.